Please login to the form below

Almac group

Almac provides the most comprehensive range of services extending from research through pharmaceutical and clinical development to commercialisation of product. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 30 years.

This is a FREE listing




Below are full profiles from other companies in this area

Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company also supports pharmaceutical and biotech clients with tech-enabled, dedicated partnerships delivered via a unique engagement model that enables life sciences companies to better address complex needs. www.genesisrg.com

View profile

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Learn more about how we are Shortening the distance from lab to life® at syneoshealth.com.

View profile

Company Details

Almac group

Telephone:+44 (0) 28 3833 2200

Address:
Almac House
20 Seagoe Industrial Estate Craigavon
BT63 5QD
United Kingdom

Latest content from PMHub

Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK. Innovative Trials
Diversifying Healthcare AI with Federated Learning
Dr. Ittai Dayan, Co-founder & CEO of Rhino Health, shares how his company is transforming the way healthcare AI solutions are created, adopted and measured. He will also explore how to create equitable access to advanced AI-based diagnostics and treatment pathways, how biopharma companies can leverage federated learning to overcome the challenges of accessing real-world data, and more. Impetus Digital
Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program.
Impetus Digital
SCIRIS ACQUIRES SOURCE HEALTH ECONOMICS
Porterhouse Medical Group